Radiotherapy in metastatic castration resistant prostate cancer patients with oligo-progression during abiraterone-enzalutamide treatment: a mono-institutional experience

BACKGROUND: Some patients experience oligo-progression during androgen receptor targeted therapy (ARTT) treatments. This progression might not indicate a real systemic drug resistance, but a selective monoclonal resistance. With the aim to delay the start of new line treatments we treated oligo-prog...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Radiat Oncol
Autors principals: Valeriani, Maurizio, Marinelli, Luca, Macrini, Serena, Reverberi, Chiara, Aschelter, Anna Maria, De Sanctis, Vitaliana, Marchetti, Paolo, Tronnolone, Lidia, Osti, Mattia Falchetto
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6857348/
https://ncbi.nlm.nih.gov/pubmed/31727093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-019-1414-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars